Search

Embecta Corp

Fermé

SecteurSoins de santé

6.21 3.85

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.66

Max

6.1

Chiffres clés

By Trading Economics

Revenu

25M

21M

Ventes

50M

272M

P/E

Moyenne du Secteur

4

47.946

BPA

0.56

Rendement du dividende

8.14

Marge bénéficiaire

7.766

Employés

1,850

EBITDA

17M

62M

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

8.14%

2.27%

Prochains Résultats

24 nov. 2026

Date du Prochain Dividende

17 déc. 2026

Date du Prochain Détachement de Dividende

4 déc. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

112M

333M

Ouverture précédente

2.36

Clôture précédente

6.21

Embecta Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 oct. 2026, 23:06 UTC

Embecta Corp's shares advanced modestly higher in after-market trading, recovering from a low point earlier in the session while remaining above its 20-day moving average.

9 oct. 2026, 19:35 UTC

Embecta Corp's shares are roughly flat, showing little change since Thursday's close, while positioned above its 20-day moving average.

8 oct. 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate wrongdoing involving its officers and directors.

7 oct. 2026, 20:08 UTC

Embecta Corp shares fell modestly, retracing from a peak earlier in the day, but remain above their 20-day moving average.

6 oct. 2026, 19:20 UTC

Embecta Corp is trading higher, supported by broader market gains and positive economic indicators, despite earlier pulling back from a session high.

5 oct. 2026, 22:31 UTC

Embecta Corp is experiencing downward pressure in after-market trading, with losses accelerating since Monday's close while remaining above its 20-day moving average.

2 oct. 2026, 23:20 UTC

Embecta Corp is seeing a notable decline in after-market trading, reaching its lowest cumulative return since Friday's close.

1 oct. 2026, 20:07 UTC

Embecta Corp is advancing, remaining well above its previous close and significantly above its 20-day moving average, despite a slight pullback earlier in the session.

30 sept. 2026, 20:02 UTC

Embecta Corp shares fell sharply after an early high, continuing a decline since Tuesday's close while remaining above the 20-day moving average.

29 sept. 2026, 20:07 UTC

News

Embecta Corp shares are declining as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing by the company's officers and directors.

28 sept. 2026, 20:12 UTC

Embecta Corp is trading lower in after-market hours, continuing a decline since Monday, though it remains above its 20-day moving average.

25 sept. 2026, 20:01 UTC

Embecta Corp is sharply higher, reaching a notable high and trading above its 20-day moving average, continuing an upward trend since Thursday's close.

24 sept. 2026, 20:07 UTC

Embecta Corp's shares advanced modestly, remaining above the 20-day moving average and near the upper end of their one-month trading range.

22 sept. 2026, 20:02 UTC

Embecta Corp is trading sharply higher, reaching a peak earlier in the session and remaining above its 20-day moving average.

21 sept. 2026, 21:21 UTC

Embecta Corp is declining in after-market trading, reflecting a significant dip since Monday's close and currently positioned in the middle of its one-month trading range.

18 sept. 2026, 20:04 UTC

Embecta Corp is trading higher, continuing its rise from Thursday and maintaining momentum above its 20-day moving average with three consecutive higher daily finishes.

16 sept. 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 sept. 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 sept. 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 sept. 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 sept. 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 sept. 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 sept. 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 sept. 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 sept. 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 sept. 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 août 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 août 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 août 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

26 août 2026, 19:36 UTC

Embecta Corp's shares are lower today, continuing a downward trend since Tuesday. Economic data shows persistent inflation, impacting market sentiment.

Comparaison

Variation de prix

Embecta Corp prévision

Note du Consensus

By TipRanks

Vente

2 ratings

0

Achat

1

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat